HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,919,452 | -4.7% | 95,953 | -48.2% | 0.03% | -11.8% |
Q3 2022 | $11,458,000 | -48.4% | 185,134 | -33.5% | 0.03% | -43.3% |
Q2 2022 | $22,211,000 | -29.1% | 278,467 | -6.5% | 0.06% | -15.5% |
Q1 2022 | $31,331,000 | +1.7% | 297,795 | +4.2% | 0.07% | +24.6% |
Q4 2021 | $30,795,000 | -0.6% | 285,784 | +1.1% | 0.06% | -3.4% |
Q3 2021 | $30,970,000 | -8.0% | 282,724 | -21.4% | 0.06% | -6.3% |
Q2 2021 | $33,679,000 | +1.9% | 359,662 | +0.2% | 0.06% | -1.6% |
Q1 2021 | $33,051,000 | -9.5% | 359,094 | -28.0% | 0.06% | -14.7% |
Q4 2020 | $36,501,000 | -9.6% | 498,988 | -4.0% | 0.08% | -21.1% |
Q3 2020 | $40,384,000 | +41.4% | 519,881 | +1.2% | 0.10% | +33.8% |
Q2 2020 | $28,552,000 | +551.9% | 513,712 | +247.4% | 0.07% | +446.2% |
Q1 2020 | $4,380,000 | -65.8% | 147,866 | -58.2% | 0.01% | -55.2% |
Q4 2019 | $12,802,000 | +22.5% | 353,643 | -7.9% | 0.03% | +11.5% |
Q3 2019 | $10,452,000 | -32.8% | 383,831 | -40.6% | 0.03% | -31.6% |
Q2 2019 | $15,550,000 | – | 646,292 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |